BUY RPG Life Sciences Limited — Pankaj Pandey, ICICI Securities
byPankaj Pandey, ICICI SecuritiesHorizon: NA (inferred 1 year)20 Aug 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·7 Sept · today
1 other SEBI-registered advisor has an active long-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·4 Sept · 3d ago
RPG Life Sciences' subsidiary, RPG Active Pharma, is acquiring the API business of Raghava Life Sciences for up to 135 crore. This acquisition includes a manufacturing facility and a portfolio of 22 c
BSE · Company Update·2 Sept · 4d ago
RPG Life Sciences' wholly owned subsidiary, RPG Active Pharma Limited, will acquire the API and intermediates business of Raghava Life Sciences Private Limited via slump sale for up to Rs. 135 crores.
BSE · Company Update·2 Sept · 4d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.